Skip to main content

Utah Medical Products Inc

UTMD
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000706698

No open-market purchases or sales by Utah Medical Products Inc insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $159.9M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Utah Medical Products Inc changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of UTMD: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders8790+3
Shares2.54M2.55M+3.85K (+0.2%)
Value$241.0M$237.5M−$3.55M (−1.5%)

New holders (6)

Institutions that held Utah Medical Products Inc at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to UTMD in Q2 2023
InstitutionSharesValue% of portfolio
Bank of Montreal12,292$1.23M0.00%
American Century Companies Inc4,975$463.7K0.00%
Squarepoint Ops LLC3,226$300.7K0.00%
Captrust Financial Advisors3,188$297.1K0.00%
Panagora Asset Management Inc2,643$246.3K0.00%
Roffman Miller Associates Inc50$4.66K0.00%

Sold out (3)

Institutions that held Utah Medical Products Inc at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of UTMD in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
SG Americas Securities, LLC1,402$133.0K
Belpointe Asset Management LLC400$37.9K
WR Wealth Planners, LLC66$6.25K